The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Hepatitis B Virus (HBV) Market During The Forecast Period 2026–2030?
Recent years have seen substantial growth in the hepatitis b virus (hbv) market size. It is projected to increase from $7.31 billion in 2025 to $7.98 billion in 2026, with a compound annual growth rate (CAGR) of 9.3%. Key drivers of this historical expansion include the elevated prevalence of hbv in Asia-Pacific, inadequate understanding of hbv treatment, poor vaccination rates in its initial years, dependence on generic antiviral drugs, and a rise in chronic liver disease cases.
The hepatitis b virus (hbv) market is expected to witness rapid expansion in the upcoming years. This market is projected to grow to $11.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. The anticipated growth over the forecast period can be attributed to increased research and development in hbv therapeutics, the expansion of government vaccination programs, the adoption of precision medicine, rising healthcare expenditure, and improvements in screening and diagnostic infrastructure. Prominent trends for the forecast period include the increasing uptake of antiviral therapies, the rise in hepatitis b vaccination programs, the development of combination therapies, a focus on managing hbv in pediatric and geriatric populations, and the expansion of screening and diagnostic services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12867&type=smp
What Drivers Are Expected To Influence The Hepatitis B Virus (HBV) Market During The Forecast Period?
The widespread occurrence of hepatitis B infection is anticipated to fuel the expansion of the hepatitis B virus market in the future. Hepatitis B, a liver condition caused by the hepatitis B virus (HBV), can be prevented with vaccination. An increase in hepatitis B infection rates could boost the need for diagnostic examinations and therapeutic solutions. For example, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency focusing on the control and prevention of disease, injury, and disability, projected 13,300 new hepatitis B infections and 69,800 new hepatitis C infections in 2023. Consequently, the significant prevalence of hepatitis B infection is set to propel the hepatitis B virus market.
What Market Segments Are Evaluated Within The Hepatitis B Virus (HBV) Market?
The hepatitis b virus (hbv) market covered in this report is segmented –
1) By Type: Acute, Chronic
2) By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery
3) By Age Group: Pediatrics, Adults, Seniors
4) By End User: Medical Providers, Patients, Healthcare Payers
Subsegments:
1) By Acute HBV: Asymptomatic Acute HBV, Symptomatic Acute HBV, Severe Acute HBV
2) By Chronic HBV: Chronic Hepatitis B (HBeAg Positive), Chronic Hepatitis B (HBeAg Negative), Chronic Hepatitis B With Compensated Liver Disease, Chronic Hepatitis B With Decompensated Liver Disease, Chronic Hepatitis B With Hepatocellular Carcinoma (HCC)
What Industry Trends Are Redefining The Hepatitis B Virus (HBV) Market?
Leading companies within the HBV market are concentrating on advancing innovative therapies through clinical trials and accelerating regulatory progress to enhance treatment efficacy and gain a competitive edge. For instance, in August 2025, Aligos Therapeutics, a US-based therapeutics company, commenced patient dosing in its Phase II B-SUPREME trial, which is evaluating ALG-000184, a first-in-class oral capsid assembly modulator for chronic hepatitis B. This randomized, double-blind study plans to enroll approximately 200 treatment-naïve adults, comparing ALG-000184 to tenofovir disoproxil fumarate over 48 weeks. The primary aim is to achieve HBV DNA levels below quantifiable limits in both HBeAg-positive and HBeAg-negative participants, with secondary measures assessing safety, pharmacokinetics, and antigen changes. Earlier Phase I data demonstrated robust antiviral activity and good tolerability, reinforcing the drug’s potential. Interim results are expected in 2026, with full topline findings projected for 2027.
Who Are The Top Market Participants Influencing The Hepatitis B Virus (HBV) Market?
Major companies operating in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Sanofi SA, GlaxoSmithKline PLC, Gilead Sciences Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arbutus Biopharma Corporation, Antios Therapeutics Inc.
Read the full hepatitis b virus (hbv) market report here:
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
Which Region Is Forecast To Lead The Hepatitis B Virus (HBV) Market In Terms Of Market Size?
North America was the largest region in the hepatitis B Virus (HBV) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis b virus (hbv) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Hepatitis B Virus (HBV) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12867&type=smp
Browse Through More Reports Similar to the Global Hepatitis B Virus (HBV) Market 2026, By The Business Research Company
Hepatitis B Virus Hbv Market Report 2026
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
Chronic Hepatitis B Market Report 2026
https://www.thebusinessresearchcompany.com/report/chronic-hepatitis-b-global-market-report
Preventive Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model